Primecap Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59B Sell
18,213,708
-243,923
-1% -$47M 2.83% 4
2025
Q4
$3.39B Sell
18,457,631
-1,471,355
-7% -$258M 2.57% 6
2025
Q3
$3.06B Sell
19,928,986
-671,060
-3% -$102M 2.34% 9
2025
Q2
$2.88B Buy
20,600,046
+269,303
+1% +$37.7M 2.28% 9
2025
Q1
$2.99B Sell
20,330,743
-179,021
-0.9% -$25.9M 2.47% 7
2024
Q4
$2.69B Sell
20,509,764
-480,259
-2% -$67.2M 2.08% 12
2024
Q3
$3.27B Sell
20,990,023
-308,595
-1% -$49.8M 2.4% 7
2024
Q2
$3.32B Sell
21,298,618
-173,970
-0.8% -$26.2M 2.41% 9
2024
Q1
$2.91B Sell
21,472,588
-20,950
-0.1% -$2.77M 2.17% 10
2023
Q4
$2.9B Sell
21,493,538
-451,145
-2% -$58.6M 2.29% 10
2023
Q3
$2.97B Sell
21,944,683
-93,967
-0.4% -$12.8M 2.51% 7
2023
Q2
$3.15B Sell
22,038,650
-656,279
-3% -$96.6M 2.64% 6
2023
Q1
$3.15B Buy
22,694,929
+201,509
+0.9% +$27.1M 2.75% 5
2022
Q4
$3.05B Sell
22,493,420
-313,635
-1% -$39.3M 2.79% 5
2022
Q3
$2.5B Sell
22,807,055
-99,855
-0.4% -$12.7M 2.42% 7
2022
Q2
$3.03B Sell
22,906,910
-252,030
-1% -$33.1M 2.71% 6
2022
Q1
$3.07B Sell
23,158,940
-186,310
-0.8% -$22.3M 2.32% 9
2021
Q4
$2.72B Sell
23,345,250
-787,875
-3% -$92.7M 1.88% 14
2021
Q3
$2.9B Sell
24,133,125
-218,972
-0.9% -$25.5M 2.05% 12
2021
Q2
$2.92B Sell
24,352,097
-604,516
-2% -$66.3M 1.96% 12
2021
Q1
$2.48B Sell
24,956,613
-97,860
-0.4% -$9.84M 1.73% 15
2020
Q4
$2.5B Sell
25,054,473
-694,558
-3% -$73.6M 1.86% 13
2020
Q3
$2.82B Sell
25,749,031
-1,081,838
-4% -$120M 2.33% 9
2020
Q2
$2.84B Sell
26,830,869
-1,489,792
-5% -$154M 2.44% 8
2020
Q1
$2.53B Sell
28,320,661
-1,070,522
-4% -$101M 2.48% 8
2019
Q4
$2.93B Sell
29,391,183
-23,415
-0.1% -$2.2M 2.13% 12
2019
Q3
$2.62B Buy
29,414,598
+392,532
+1% +$34M 2.1% 10
2019
Q2
$2.4B Buy
29,022,066
+850,488
+3% +$66.7M 1.77% 12
2019
Q1
$2.28B Buy
28,171,578
+97,615
+0.3% +$7.69M 1.68% 17
2018
Q4
$2.13B Buy
28,073,963
+374,320
+1% +$29.2M 1.73% 14
2018
Q3
$2.19B Buy
27,699,643
+1,182,006
+4% +$89.4M 1.48% 19
2018
Q2
$1.86B Buy
26,517,637
+734,918
+3% +$52.9M 1.38% 20
2018
Q1
$1.8B Buy
25,782,719
+2,776,402
+12% +$192M 1.35% 22
2017
Q4
$1.6B Buy
23,006,317
+1,288,552
+6% +$86.9M 1.23% 23
2017
Q3
$1.47B Buy
21,717,765
+2,767,590
+15% +$175M 1.22% 22
2017
Q2
$1.29B Buy
18,950,175
+1,794,700
+10% +$117M 1.11% 26
2017
Q1
$1.07B Buy
17,155,475
+4,165,337
+32% +$242M 0.97% 29
2016
Q4
$710M Buy
12,990,138
+4,333,475
+50% +$246M 0.7% 44
2016
Q3
$569M Buy
8,656,663
+973,688
+13% +$63.6M 0.57% 51
2016
Q2
$464M Buy
7,682,975
+1,140,837
+17% +$66.3M 0.49% 57
2016
Q1
$368M Buy
6,542,138
+6,047,688
+1,223% +$363M 0.38% 65
2015
Q4
$33.6M Buy
494,450
+402,500
+438% +$26.4M 0.03% 184
2015
Q3
$5.85M Buy
+91,950
New +$6.05M 0.01% 238

Other funds holding AZN